CRISPR: The rapidly evolving
science of genome editing

CRISPR has captured the world’s attention. Scientists are puzzling out how to exploit the tool to improve human health. CRISPR companies have cautiously begun testing specific gene-editing therapies in people. And these advances have come with shortcomings, as well: There have been technical obstacles to overcome, challenges with delivery of CRISPR to the right place in the body, and deep ethical concerns about permanently rewriting genomes not just for an individual but for generations to come.

In this latest eBook, we've curated a selection of recent STAT stories charting these discoveries, the businesses being built on them, and their potential impact on all our lives. We hope you enjoy.

.pdf

E-BOOK

Underwritten by

Please enter your information below.

All fields marked with * are required

Synthego is a leading provider of genome engineering solutions. The company’s product portfolio includes software and synthetic RNA kits designed for CRISPR genome editing and research. With next-generation informatics and machine learning, Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.

About the sponsor

Reporting from the frontiers of health and medicine